A Polymer Coated Cicaprost-Eluting Stent Increases Neointima Formation and Impairs Vessel Function in the Rabbit Iliac Artery — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
A Polymer Coated Cicaprost-Eluting Stent Increases Neointima Formation and Impairs Vessel Function in the Rabbit Iliac Artery
Biomedical Engineering Department, University of Strathclyde, Glasgow, UK
,
Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK
,
Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK
,
Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK
,
Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK
1 Biomedical Engineering Department, University of Strathclyde, Glasgow, UK
2 Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK
3 Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK
4 Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK
5 Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK
Drug-eluting stents have been successful in reducing in-stent restenosis but are not suitable for all lesion types and have been implicated in causing late stent thrombosis due to incomplete regeneration of the endothelial cell layer. In this study we implanted stents coated with cicaprost, a prostacyclin analogue with a long plasma half-life and antiproliferative effects on vascular smooth muscle cells, into the iliac arteries of rabbits. At 28-day follow-up we compared neointima formation within the stented vessels and vascular function in adjacent vessels, to assess if cicaprost could reduce restenosis without impairing vessel function. Arteries implanted with cicaprost eluting stents had significantly more neointima compared to bare metal stents. In adjacent segments of artery, endothelium-dependent relaxation was impaired by the cicaprost-eluting stent but vasodilation to an endothelium-independent vasodilator was maintained. We conclude that the presence of the polymer and sub-optimal release of cicaprost from the stent may be responsible for the increased neointma and impaired functional recovery of the endothelium observed. Further experiments should be aimed at optimising release of cicaprost and exploring different stent polymer coatings.
Babapulle, M.N., Joseph, L., Bélisle, P., Brophy, J.M. and Eisenberg, M.J. (2004) A Hierarchical Bayesian Meta-Analysis of Randomised Clinical Trials of Drug-Eluting Stents. Lancet, 364, 583-591. http://dx.doi.org/10.1016/S0140-6736(04)16850-5
Serruys, P.W., Morice, M.C., Kappetein, A.P., Colombo, A., Holmes, D.R., Mack, M.J., Stahle, E., Feldman, T.E., van den Brand, M., Bass, E.J., Van Dyck, N., Leadley, K., Dawkins, K.D. and Mohr, F.W. (2009) Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease. New England Journal of Medicine, 360, 961-972. http://dx.doi.org/10.1056/NEJMoa0804626
Farkouh, M.E., Domanski, M., Sleeper, L.A., Siami, F.S., Dangas, G., Mack, M., Yang, M., Cohen, D.J., Rosenberg, Y., Solomon, S.D., Desai, A.S., Gersh, B.J., Magnuson, E.A., Lansky, A., Boineau, R., Weinberger, J., Ramanathan, K., Sousa, J.E., Rankin, J., Bhargava, B., Buse, J., Hueb, W., Smith, C.R., Muratov, V., Bansilal, S., King, 3rd, S., Bertrand, M. and Fuster, V. (2012) Strategies for Multivessel Revascularization in Patients with Diabetes. New England Journal of Medicine, 367, 2375-2384. http://dx.doi.org/10.1056/NEJMoa1211585
Joner, M., Finn, A.V., Farb, A., Mont, E.K., Kolodgie, F.D., Ladich, E., Kutys, R., Skorija, K., Gold, H.K. and Virmani, R. (2006) Pathology of Drug-Eluting Stents in Humans: Delayed Healing and Late Thrombotic Risk. Journal of the American College of Cardiology, 48, 193-202. http://dx.doi.org/10.1016/j.jacc.2006.03.042
Nakano, M., Otsuka, F., Yahagi, K., Sakakura, K., Kutys, R., Ladich, E.R., Finn, A.V., Kolodgie, F.D. and Virmani, R. (2013). Human Autopsy Study of Drug-Eluting Stents Restenosis: Histomorphological Predictors and Neointimal Characteristics. European Heart Journal, 34, 3304-3313. http://dx.doi.org/10.1093/eurheartj/eht241
Hofma, S.H., van der Giessen, W.J., van Dalen, B.M., Lemos, P.A., McFadden, E.P., Sianos, G., Ligthart, J.M., van Essen, D., de Feyter, P.J. and Serruys, P.W. (2006) Indication of Long-Term Endothelial Dysfunction after Sirolimus-Eluting Stent Implantation. European Heart Journal, 27, 166-170. http://dx.doi.org/10.1093/eurheartj/ehi571
Shin, D.I., Kim, P.J., Seung, K.B., Kim, D.B., Kim, M.J., Chang, K., Lim, S.M., Jeon, D.S., Chung, W.S., Baek, S.H. and Lee, M.Y. (2007) Drug-Eluting Stent Implantation Could Be Associated with Long-Term Coronary Endothelial Dysfunction. International Heart Journal, 48, 553-567. http://dx.doi.org/10.1536/ihj.48.553
Fuke, S., Maekawa, K., Kawamoto, K., Saito, H., Sato, T., Hioka, T. and Ohe, T. (2007) Impaired Endothelial Vasomotor Function after Sirolimus-Eluting Stent Implantation. Circulation Journal, 71, 220-225. http://dx.doi.org/10.1253/circj.71.220
Hamilos, M.I., Ostojic, M., Beleslin, B., Sagic, D., Mangovski, L., Stojkovic, S., Nedeljkovic, M., Orlic, D., Milosavljevic, B., Topic, D., Karanovic, N., Wijns, W., NOBORI CORE Investigators (2008) Differential Effects of Drug-Eluting Stents on Local Endothelium-Dependent Coronary Vasomotion. Journal of the American College of Cardiology, 51, 2123-2129. http://dx.doi.org/10.1016/j.jacc.2007.12.059
Sousa, J.E., Serruys, P.W. and Costa, M.A. (2003) New Frontiers in Cardiology: Drug-Eluting Stents: Part II. Circulation, 107, 2383-2389. http://dx.doi.org/10.1161/01.CIR.0000069331.67148.2F
Carter, A.J., Laird, J.R., Farb, A., Kufs, W., Wortham, D.C. and Virmani, R. (1994) Morphologic Characteristics of Lesion Formation and Time Course of Smooth Muscle Cell Proliferation in a Porcine Proliferative Restenosis Model. Journal of the American College of Cardiology, 24, 1398-1405. http://dx.doi.org/10.1016/0735-1097(94)90126-0
Kornowski, R., Hong, M.K., Tio, F.O., Bramwell, O., Wu, H. and Leon, M.B. (1998) In-Stent Restenosis: Contributions of Inflammatory Responses and Arterial Injury to Neointimal Hyperplasia. Journal of the American College of Cardiology, 31, 224-230. http://dx.doi.org/10.1016/S0735-1097(97)00450-6
Vane, J.R. and Botting, R.M. (1995) Pharmacodynamic Profile of Prostacyclin. American Journal of Cardiology, 75, 3A-10A. http://dx.doi.org/10.1016/S0002-9149(99)80377-4
Zucker, T.P., Bönisch, D., Hasse, A., Grosser, T., Weber, A.A. and Schrör, K. (1998) Tolerance Development to Antimitogenic Actions of Prostacyclin but Not of Prostaglandin E1 in Coronary Artery Smooth Muscle Cells. European Journal of Pharmacology, 345, 213-220. http://dx.doi.org/10.1016/S0014-2999(98)00022-3
Voisard, R., Stemberger, A., Baur, R., Herter, T., Hähnel, I., Resch, A., Seliger, C., Hemmer, W., Hannekum, A., Hombach, V. and Alt, E. (2005) Triple-Coated Stents (Hirudin/Iloprost/Paclitaxel): An in Vitro Approach for Characterizing the Antiproliferative Potential of Each Individual Compound. International Journal of Cardiology, 102, 425-433. http://dx.doi.org/10.1016/j.ijcard.2004.05.059
Hata, A.N. and Breyer, R.M. (2004) Pharmacology and Signaling of Prostaglandin Receptors: Multiple Roles in Inflammation and Immune Modulation. Pharmacology and Therapeutics, 103, 147-166. http://dx.doi.org/10.1016/j.pharmthera.2004.06.003
Della Bella, S., Molteni, M., Mocellin, C., Fumagalli, S., Bonara, P. and Scorza, R. (2001) Novel Mode of Action of Iloprost: In Vitro Down-Regulation of Endothelial Cell Adhesion Molecules. Prostaglandins and Other Lipid Mediators, 65, 73-83. http://dx.doi.org/10.1016/S0090-6980(01)00131-9
Alt, E., Haehnel, I., Beilharz, C., Prietzel, K., Preter, D., Stemberger, A., Fliedner, T., Erhardt, W. and Sch?mig, A. (2000) Inhibition of Neointima Formation after Experimental Coronary Artery Stenting: A New Biodegradable Stent Coating Releasing Hirudin and the Prostacyclin Analogue Iloprost. Circulation, 101, 1453-1458. http://dx.doi.org/10.1161/01.CIR.101.12.1453
McCormick, C., Jones, R.L., Kennedy, S. and Wadsworth, R.M. (2010) Activation of Prostanoid EP Receptors by Prostacyclin Analogues in Rabbit Iliac Artery: Implications for Anti-Restenotic Potential. European Journal of Pharmacology, 641, 160-167. http://dx.doi.org/10.1016/j.ejphar.2010.04.035
Abramovitz, M., Adam, M., Boie, Y., Carrière, M., Denis, D., Godbout, C., Lamontagne, S., Rochette, C., Sawyer, N., Tremblay, N.M., Belley, M., Gallant, M., Dufresne, C., Gareau, Y., Ruel, R., Juteau, H., Labelle, M., Ouimet, N. and Metters, K.M. (2000) The Utilization of Recombinant Prostanoid Receptors to Determine the Affinities and Selectivities of Prostaglandins and Related Analogs. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids, 1483, 285-293. http://dx.doi.org/10.1016/s1388-1981(99)00164-x
Coats, P., Kennedy, S., Pyne, S., Wainwright, C.L. and Wadsworth, R.M. (2008) Inhibition of Non-Ras Protein Farnesylation Reduces In-Stent Restenosis. Atherosclerosis, 197, 515-523. http://dx.doi.org/10.1016/j.atherosclerosis.2007.06.007
Malik, N., Gunn, J., Holt, C.M., Shepherd, L., Francis, S.E., Newman, C.M., Crossman, D.C. and Cumberland, D.C. (1998) Intravascular Stents: A New Technique for Tissue Processing for Histology, Immunohistochemistry, and Transmission Electron Microscopy. Heart, 80, 509-516. http://dx.doi.org/10.1136/hrt.80.5.509
Gunn, J., Arnold, N., Chan, K.H., Shepherd, L., Cumberland, D.C. and Crossman, D.C. (2002) Coronary Artery Stretch versus Deep Injury in the Development of In-Stent Neointima. Heart, 88, 401-405. http://dx.doi.org/10.1136/heart.88.4.401
Levitt, M.A., Dryjski, M., Tluczek, J. and Bjornsson, T.D. (1991) Evaluation of a Prostacyclin Analog, Iloprost, and a Thromboxane A2 Receptor Antagonist, Daltroban, in Experimental Intimal Hyperplasia. Prostaglandins, 41, 1-6. http://dx.doi.org/10.1016/0090-6980(91)90099-2
Banning, A., Brewer, L., Wendt, M., Groves, P.H., Cheadle, H., Penny, W.J. and Crawford, N. (1997) Local Delivery of Platelets with Encapsulated Iloprost to Balloon Injured Pig Carotid Arteries: Effect on Platelet Deposition and Neointima Formation. Thrombosis and Haemostasis, 77, 190-196.
Isogaya, M., Yamada, N., Koike, H., Ueno, Y., Kumagai, H., Ochi, Y., Okazaki, S. and Nishio, S. (1995) Inhibition of Restenosis by Beraprost Sodium (a Prostaglandin I2 Analogue) in the Atherosclerotic Rabbit Artery after Angioplasty. Journal of Cardiovascular Pharmacology, 25, 947-952. http://dx.doi.org/10.1097/00005344-199506000-00013
Schwartz, R.S., Chronos, N.A. and Virmani, R. (2004) Preclinical Restenosis Models and Drug-Eluting Stents: Still Important, Still Much to Learn. Journal of the American College of Cardiology, 44, 1373-1385. http://dx.doi.org/10.1016/j.jacc.2004.04.060
Blindt, R., Bosserhoff, A.K., vom Dahl, J., Hanrath, P., Schror, K., Hohlfeld, T. and Meyer-Kirchrath, J. (2002) Activation of IP and EP3 Receptors Alters cAMP-Dependent Cell Migration. European Journal of Pharmacology, 444, 31-37. http://dx.doi.org/10.1016/S0014-2999(02)01607-2
Murata, T., Ushikubi, F., Matsuoka, T., Hirata, M., Yamasaki, A., Sugimoto, Y., Ichikawa, A., Aze, Y., Tanaka, T., Yoshida, N., Ueno, A., Oh-ishi, S. and Narumiya, S. (1997) Altered Pain Perception and Inflammatory Response in Mice Lacking Prostacyclin Receptor. Nature, 388, 678-682. http://dx.doi.org/10.1038/41780
Fetalvero, K.M., Martin, K.A. and Hwa, J. (2007) Cardioprotective Prostacyclin Signaling in Vascular Smooth Muscle. Prostaglandins and Other Lipid Mediators, 82, 109-118. http://dx.doi.org/10.1016/j.prostaglandins.2006.05.011
Sirois, M.G., Simons, M., Kuter, D.J., Rosenberg, R.D. and Edelman, E.R. (1997) Rat Arterial Wall Retains Myointimal Hyperplastic Potential Long after Arterial Injury. Circulation, 96, 1291-1298. http://dx.doi.org/10.1161/01.CIR.96.4.1291
Banai, S., Gertz, S.D., Gavish, L., Chorny, M., Perez, L.S., Lazarovichi, G., Ianculuvich, M., Hoffmann, M., Orlowski, M., Golomb, G. and Levitzki, A. (2004) Tyrphostin AGL-2043 Eluting Stent Reduces Neointima Formation in Porcine Coronary Arteries. Cardiovascular Research, 64, 165-171. http://dx.doi.org/10.1016/j.cardiores.2004.06.013
Tamai, H., Igaki, K., Kyo, E., Kosuga, K., Kawashima, A., Matsui, S., Komori, H., Tsuji, T., Motohara, S. and Uehata, H. (2000) Initial and 6-Month Results of Biodegradable Poly-l-Lactic Acid Coronary Stents in Humans. Circulation, 102, 399-404. http://dx.doi.org/10.1161/01.CIR.102.4.399
Lincoff, A.M., Furst, J.G., Ellis, S.G., Tuch, R.J. and Topol, E.J. (1997) Sustained Local Delivery of Dexamethasone by a Novel Intravascular Eluting Stent to Prevent Restenosis in the Porcine Coronary Injury Model. Journal of the American College of Cardiology, 29, 808-816. http://dx.doi.org/10.1016/S0735-1097(96)00584-0
Mani, G., Feldman, M.D., Patel, D. and Agrawal, C.M. (2007) Coronary Stents: A Materials Perspective. Biomaterials, 28, 1689-1710. http://dx.doi.org/10.1016/j.biomaterials.2006.11.042
van der Giessen, W.J., Lincoff, A.M., Schwartz, R.S., van Beusekom, H.M., Serruys, P.W., Holmes Jr., D.R. Ellis, S.G. and Topol, E.J. (1996) Marked Inflammatory Sequelae to Implantation of Biodegradable and Nonbiodegradable Polymers in Porcine Coronary Arteries. Circulation, 94, 1690-1697. http://dx.doi.org/10.1161/01.CIR.94.7.1690
Moses, J.W., Leon, M.B., Popma, J.J., Fitzgerald, P.J., Holmes, D.R., O’Shaughnessy, C., Caputo, R.P., Kereiakes, D.J., Williams, D.O., Teirstein, P.S., Jaeger, J.L. and Kuntz, R.E. (2003) Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery. The New England Journal of Medicine, 349, 1315-1323. http://dx.doi.org/10.1056/NEJMoa035071